RPG Life Sciences announced that the Board of Directors of the Company at its meeting held on 30 April 2024, inter alia, have recommended the final dividend of Rs 16 per equity Share (i.e. 200%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of RPG Life Sciences rose 27.92% to Rs 13.24 crore in the quarter ended March 2024 as against Rs 10.35 crore during the previous quarter ended March 2023. Sales rose 7.17% to Rs 126.99 crore in the quarter ended March 2024 as against Rs 118.49 crore during the previous quarter ended March 2023.For the full year,net profit rose 29.60% to Rs 87.66 crore in the year ended March 2024 as against Rs 67.64 crore during the previous year ended March 2023. Sales rose 13.50% to Rs 582.05 crore in the year ended March 2024 as against Rs 512.81 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales126.99118.49 7 582.05512.81 14 OPM %16.3213.43 -22.0220.02 - PBDT22.2317.70 26 134.91107.18 26 PBT17.7413.81 28 117.8491.68 29 NP13.2410.35 28 87.6667.64 30 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 30 April 2024.Powered by Capital Market - Live News

Net profit of RPG Life Sciences rose 38.46% to Rs 26.46 crore in the quarter ended December 2023 as against Rs 19.11 crore during the previous quarter ended December 2022. Sales rose 17.69% to Rs 153.70 crore in the quarter ended December 2023 as against Rs 130.60 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales153.70130.60 18 OPM %24.6622.37 - PBDT39.6829.65 34 PBT35.5425.74 38 NP26.4619.11 38 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 1 February 2024.Powered by Capital Market - Live News